Tabe 2.

Pt #	Dx	Cellularity %	Megs	Druf Megs	BM blasts	MPO	Esterase	FAB	Cytogenetics at diagnosis
1	Ph AML	70-80	decreased	no	97	6%	neg	M1	46,XX,t(9;22)(q34;q11.2)[20]
2	Ph AML	50-60	decreased	no	65	neg	neg	M0	46,XY,t(9;22)(q34;q11.2)[19]
3	Ph AML	40-50	usual	no	63	68%	neg	M4	46,XY,der(7)inv(7)(q11.2q36)del(7)(q22q31), t(9;22)(q34;q11.2)[19]/46,XY[1]
4	Ph AML	90-100	decreased	no	82	36%	2%	M2	46,XY,t(9;22)(q34;q11.2)[1]/45,XY, -7,t(9;22)(q34;q11.2)[18]/46,XY[1]
5	Ph AML	95-100	decreased	no	87	70%	5%	M1	46,XY,t(9;22)(q34;q11.2)[20]
6	Ph AML	90-100	usual	no	60	40%	neg	M2	46,XX,t(9;22)(q34;q11.2)[20]
7	Ph AML	70-80	usual	no	69	70	40%	M4	46,XX,t(9;22)(q34;q11.2)[18]/46,XX[1]
8	Ph AML	50-60	increased	yes	33	1	2%	M7	46,XX,t(9;22)(q34;q11.2)[20]
9	Ph AML	80-90	absent	NA	88	1	neg	M0	46,XY,der(9)inv(9)(p12q13)t(9;22)(q34;q11.2)[3] /46,XY, inv(9)[7]
10	CML BP	95-100	decreased	yes	76	6	neg	M2	46,XY,t(9;22)(q34;q11.2)[17]/46,XY[3]
11	CML BP	70-80	decreased	yes	36	40	neg	M2	46,XX,t(8;11)(p11.2;p15),t(9;22)(q34;q11.2)[20]
12	CML BP	95-100	decreased	no	64	1	neg	M0	55,XY,+8,t(9;22)(q34;q11.2),+13,+14,+14,+16, +18,+19,+20,+der(22)t(9;22)[6]/46,XY[14]
13	CML BP	30-40	increased	yes	65	neg	neg	M2	46,X,-Y,+8,t(9;22)(q34;q11.2)[6]/46,X, - Y,+8,t(9;22)(q34;q11.2),inv(16)(p13q22)[7]/ 47,XY,+Y[2]/46,XY[5]
14	CML BP	95-100	increased	yes	38	20	neg	M7	46,XY,t(3;21)(q26.2;q22),del(7)(q22), t(9;22)(q34;q11.2) [2]/46,XY,t(3;21)(q26.2;q22), t(4;15)(p16;q22),del(7)(q22),t(9;22)(q34;q11.2)[5]/ 46,XY,t(3;14)(q27;q24),t(3;21)(q26.2;q22),del(7) (q22),t(9;22)(q34;q11.2)[5]/46,XX[11]